ATE267608T1 - Verwendung von fsh zur behandlung von infertilität - Google Patents

Verwendung von fsh zur behandlung von infertilität

Info

Publication number
ATE267608T1
ATE267608T1 AT01900491T AT01900491T ATE267608T1 AT E267608 T1 ATE267608 T1 AT E267608T1 AT 01900491 T AT01900491 T AT 01900491T AT 01900491 T AT01900491 T AT 01900491T AT E267608 T1 ATE267608 T1 AT E267608T1
Authority
AT
Austria
Prior art keywords
fsh
treat infertility
infertility
treat
Prior art date
Application number
AT01900491T
Other languages
English (en)
Inventor
Ernest Loumaye
Louise Duerr-Meyers
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26072975&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE267608(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP00302840A external-priority patent/EP1142582A1/de
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of ATE267608T1 publication Critical patent/ATE267608T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01900491T 2000-01-27 2001-01-09 Verwendung von fsh zur behandlung von infertilität ATE267608T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00300591 2000-01-27
EP00302840A EP1142582A1 (de) 2000-04-04 2000-04-04 Verwendung von FSH zur Behandlung von Infertilität
PCT/GB2001/000065 WO2001054715A1 (en) 2000-01-27 2001-01-09 Use of fsh for treating infertility

Publications (1)

Publication Number Publication Date
ATE267608T1 true ATE267608T1 (de) 2004-06-15

Family

ID=26072975

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01900491T ATE267608T1 (de) 2000-01-27 2001-01-09 Verwendung von fsh zur behandlung von infertilität

Country Status (29)

Country Link
US (1) US7291593B2 (de)
EP (2) EP1250148B2 (de)
JP (1) JP5170928B2 (de)
KR (2) KR100871499B1 (de)
CN (1) CN1418107A (de)
AR (1) AR027287A1 (de)
AT (1) ATE267608T1 (de)
AU (1) AU783121B2 (de)
BG (1) BG65915B1 (de)
BR (1) BR0107881A (de)
CA (1) CA2397680A1 (de)
CZ (1) CZ302835B6 (de)
DE (1) DE60103503T3 (de)
DK (1) DK1250148T4 (de)
EA (1) EA004924B1 (de)
EE (1) EE05444B1 (de)
ES (1) ES2217113T5 (de)
HR (1) HRP20020630A2 (de)
HU (1) HU230833B1 (de)
IL (2) IL150837A0 (de)
MX (1) MXPA02007233A (de)
NO (1) NO324626B1 (de)
PL (1) PL211113B1 (de)
PT (1) PT1250148E (de)
RS (1) RS50805B (de)
SI (1) SI1250148T2 (de)
SK (1) SK287717B6 (de)
TR (1) TR200401810T4 (de)
WO (1) WO2001054715A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002324183B2 (en) * 2001-09-12 2007-10-25 Merck Serono Sa Use of hCG and LH in controlled ovarian hyperstimulation
DE60238490D1 (de) * 2001-09-12 2011-01-13 Merck Serono Sa Verwendung von humanem choriongonadotropin (hcg) und luteinisierendem hormon (lh) zur regulierten hyperstimulation der eierstöcke
HRP20040087A2 (en) * 2001-09-12 2004-12-31 Applied Research Systems USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATION
UA88879C2 (en) * 2003-09-02 2009-12-10 Эплайд Рисерч Системз Эрс Холдинг Н.В. Fsh glycosylation mutant
US7481748B2 (en) * 2005-09-22 2009-01-27 Kurt Manufacturing Company, Inc. Locking mechanism for a bicycle trainer
EP2150271A1 (de) * 2007-05-11 2010-02-10 The Texas A & M Univsersity System Hormonnormalisierungstherapie und ihre verwendung
AR081755A1 (es) 2010-04-02 2012-10-17 Hanmi Holdings Co Ltd Formulacion de accion prolongada de la hormona estimuladora de los foliculos donde se usa un fragmento de inmunoglobulina, metodo de preparacion y metodo para tratar a un sujeto que sufre un trastorno reproductivo
WO2015089656A1 (en) * 2013-12-20 2015-06-25 Fertilify Inc. Compositions comprising vitamin c, vitamin e, and coenzyme q10 and use thereof for promoting female fertility and reproductive health
SI3973982T1 (sl) * 2017-09-01 2024-10-30 Ferring B. V. Sestavek za nadzorovano stimulacijo jajčnikov

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725579A (en) * 1985-02-21 1988-02-16 Serono Laboratories, Inc. Method of in vitro fertilization by a unique combination of gonadotropins

Also Published As

Publication number Publication date
EA004924B1 (ru) 2004-10-28
KR100871502B1 (ko) 2008-12-05
EE200200415A (et) 2003-12-15
CN1418107A (zh) 2003-05-14
SI1250148T2 (sl) 2008-10-31
YU56702A (sh) 2005-09-19
TR200401810T4 (tr) 2004-09-21
CZ302835B6 (cs) 2011-11-30
BG106943A (bg) 2003-02-28
DK1250148T3 (da) 2004-08-16
DK1250148T4 (da) 2008-09-22
EP1250148A1 (de) 2002-10-23
EP1442748A1 (de) 2004-08-04
WO2001054715A1 (en) 2001-08-02
DE60103503D1 (de) 2004-07-01
KR20070087253A (ko) 2007-08-27
IL150837A (en) 2010-12-30
CA2397680A1 (en) 2001-08-02
NO324626B1 (no) 2007-11-26
US20030158106A1 (en) 2003-08-21
RS50805B (sr) 2010-08-31
HUP0204324A2 (en) 2003-05-28
PL356925A1 (en) 2004-07-12
SK287717B6 (en) 2011-07-06
NO20023354L (no) 2002-09-24
JP2003520823A (ja) 2003-07-08
BR0107881A (pt) 2003-04-01
PL211113B1 (pl) 2012-04-30
SI1250148T1 (en) 2004-08-31
AR027287A1 (es) 2003-03-19
ES2217113T3 (es) 2004-11-01
AU783121B2 (en) 2005-09-29
US7291593B2 (en) 2007-11-06
DE60103503T2 (de) 2005-06-09
KR20020081273A (ko) 2002-10-26
IL150837A0 (en) 2003-02-12
DE60103503T3 (de) 2008-12-24
SK10962002A3 (sk) 2002-12-03
HRP20020630A2 (en) 2004-12-31
EA200200801A1 (ru) 2003-02-27
BG65915B1 (bg) 2010-05-31
HU230833B1 (hu) 2018-07-30
EE05444B1 (et) 2011-08-15
MXPA02007233A (es) 2003-02-12
CZ20022555A3 (cs) 2002-11-13
NO20023354D0 (no) 2002-07-11
HUP0204324A3 (en) 2004-12-28
EP1250148B1 (de) 2004-05-26
JP5170928B2 (ja) 2013-03-27
PT1250148E (pt) 2004-09-30
AU2532101A (en) 2001-08-07
KR100871499B1 (ko) 2008-12-05
ES2217113T5 (es) 2008-11-01
EP1250148B2 (de) 2008-07-02

Similar Documents

Publication Publication Date Title
EP1324780A4 (de) Methoden zur behandlung von herzarrhythmie
ATE365042T1 (de) Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
ATE419856T1 (de) Verwendung von rimexolon zur behandlung von augentrockenheit
ATE401909T1 (de) Verwendung von löslichen ctla4-mutanten zur behandlung von rheumatoider arthritis
ATE308364T1 (de) Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen
ATE288748T1 (de) Verwendung von retigabin zur behandlung von neuropathischen schmerzen
DE60105295D1 (de) Chinazolinderivate zur behandlung von tumoren
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60123238D1 (de) Zusammensetzungen zur behandlung von autoimmunkrankheiten
ATE353218T1 (de) Verwendung von epinastin zur behandlung von allergischer rhinitis/konjunktivitis
DE60136477D1 (de) Retinoide zur behandlung von emphysem
ATE338552T1 (de) Verwendungen von et743 zur behandlung von krebs
ATE279386T1 (de) Retinoide zur behandlung von emphysem
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
ATE254913T1 (de) Diacerein zur behandlung von psoriasis
ATE339955T1 (de) Verwendung von escitalopram zur behandlung von generalisierten angstzuständen
DE60103503D1 (de) Verwendung von fsh zur behandlung von infertilität
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
DE60104791D1 (de) Cyclobutendion-Derivate zur Behandlung von Artherosclerose
DE60103685D1 (de) Behandlung von Poriomania
ATE317261T1 (de) Verwendung von mirtazapin zur behandlung von schlafstörungen
DE60120990D1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
ATE270545T1 (de) Verwendung von nmda antagonisten zur behandlung des reizkolons
ATE404203T1 (de) Verwendung von desoxypeganin zur behandlung der klinischen depression
DE60130524D1 (de) Verfahren zur elektrochemischen Behandlung von Artikeln

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1250148

Country of ref document: EP

UEP Publication of translation of european patent specification

Ref document number: 1250148

Country of ref document: EP